To investigate the function of UHRF1 in B-ALL cell lines, CRISPR-Cas9 technology was utilized to knock out UHRF1 in B-ALL cells, and a significant decrease in cell proliferation was observed (Figs. 2A, B and S3A). Here, UHRF1 is linked to acute lymphoblastic leukemia.